Journal
CURRENT MEDICINAL CHEMISTRY
Volume 30, Issue 8, Pages 953-973Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867329666220408112735
Keywords
Skin cancers; biomarkers; aptamers; biophysical methods; imaging methods; diagnostic; probes
Ask authors/readers for more resources
Cancer diseases, particularly skin cancers, pose a significant health threat. Early diagnosis is crucial for effective treatment, and aptamers offer novel possibilities in this area by specifically binding cancer biomarkers. They are increasingly used as diagnostic probes in imaging and targeted therapy. This review highlights the recent advances achieved in skin cancer diagnostics and treatment through the combination of aptamers with basic or modern technologies.
Cancer diseases have been one of the biggest health threats for the last two decades. Approximately 9% of all diagnosed cancers are skin cancers, including melanoma and non-melanoma. In all cancer cases, early diagnosis is essential to achieve efficient treatment. New solutions and advanced techniques for rapid diagnosis are constantly being sought. Aptamers are single-stranded RNA or DNA synthetic sequences or peptides, which offer novel possibilities to this area of research by specifically binding selected molecules, the so-called cancer biomarkers. Nowadays, they are widely used as diagnostic probes in imaging and targeted therapy. In this review, we have summarized the recently made advances in diagnostics and treatment of skin cancers, which have been achieved by combining aptamers with basic or modern technologies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available